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IN a previous paper (Cohen and Cohen, 1956), it was shown that a significant
radiosensitization ofestablished C3H mammary tumourisografts could be induced
by means of a second inoculation of the hosts with radiation-attenuated tumour
fragments prior to treatment. It was noted at the time that the best results were
obtained with the largest attenuation dose used (5000 r) provided the attenuated
inoculum was given after implantation of the unmodified tumour graft, and the
treatment ofthe established growth followed at least two weeks after inoculation
of the attenuated material. Some questions concerning the optimal attenuation
procedure, the possibility of increasing the effect by "booster" inocula, and the
specificity of the sensitizing tissue, were not fully investigated. The following
series ofexperiments were consequently designed to elucidate these points.
MATERIALS AND METHODS
Experimental design
Young adult male mice of the C3H/Cg strain were used as tumour recipients
in all experiments. In order to maintain as uniform a tumour source as possible,
a single autogenous mammary adenocarcinoma, arising in a female of the strain,
was serially transplanted for ten generations in a group of mice who constituted
a pool of tumour donors for all the experimental groups.
Each of 149 recipient experimental mice was inoculated subcutaneously in
the right axillary area with a fragment of the tumour introduced with a trocar
and cannula. When the isografts became palpable (about 2 or 3 weeks later),
the second, or attentuated, inoculum was given subcutaneously into the left
flank. The animalsweredivided, accordingto the typeofsecondinoculumreceived,
into the 12 experimental categories listed in Table I.
In two groups, attenuated tumour inocula were prepared from isografts
minced with a fine scissors and irradiated with 7000 r and 10,000 r respectively,
in a plastic welled slide immediately before implantation. At these dose levels
there were no "takes" of any of the irradiated tumour implants.
A further two groups were given repeated "booster" inocula of additional
tumour fragments attenuated at the two dose levels. In addition to the first
attenuated implant given about three weeks before treatment of the tumour
in situ, the mice were again inoculated one week before, three weeks after treat-
ment, and at monthly intervals thereafter.
In another category, tumour fragments were irradiated with 7000 r and
emulsified in an equal volume of Freund's adjuvant complete with M. butyricum
suspension (" Bacto-Adjuvant ", Difco) prior to inoculation.A. COHEN AND L. COHEN
Two groups of mice received cytolyzed tumour material. A tumour was finely
minced and suspended in twice its volume of distilled water in an aluminium
cylinder for 10 minutes at room temperature. It was then frozen at - 70° C.
in a solid CO2-alcohol mixture for 5 minutes, and thawed in a water bath at 40° C.
for 10 minutes. The freeze-thawing procedure was repeated 5 times. A portion
ofthe cytolyzedmaterialwasthenirradiated with 7000 r, andfragments inoculated
into the left flank of one group of tumour-bearing mice, while an unirradiated
portion was similarly inoculated into a second group.
Three other groups of tumour-bearing mice received inocula of skin removed
from a newborn C3H mouse, finely minced and unirradiated, or irradiated with
7000 r or 10,000 r respectively, prior to implantation.
Another group was inoculated with spleen removed from an adult C3H mouse,
minced into fragments and irradiated with 7000 r prior to implantation.
As controls, a number of tumour-bearing mice from the same series, who had
received no additional inoculations of any type, were treated concomitantly
with the last of the experimental groups.
Finally, some spontaneous tumours were similarly tested using attenuated
autografts. The many difficulties in treating autogenous tumours in this strain
were discussed in an earlier paper (Cohen and Cohen, 1953a), but it was considered
important to investigate whether radiosensitization could be induced also in
mice bearing tumours that arose spontaneously from their own tissues. Ten
female tumour-bearing mice were accordingly selected; small biopsies of the
turnour were removed by surgical excision, and irradiated with 7000 r as described
above. The attenuated autografts were then re-inoculated subcutaneously by
trocar and cannula. The subsequent procedure was exactly as described above
for isografts.
The diameters ofthe tumours at the time oftreatment in the 44 mice receiving
isografts attenuated with 10,000 r averaged 13.0 mm., with a standard deviation
of4.7 mm. The 72 tumours inthe 7000 r attenuation categoryhada mean diameter
of 12.6 mm., standard deviation 3.5 mm. In the 33 controls, the values were
11-8 and 3.0 mm. respectively. There were no perceptible differences in tumour
growth rates among the various groups, and each tumour was irradiated in situ
with 4200 r when it had attained a diameter of about 1 cm., that is four to seven
weeks after implantation, and between two and five weeks after the second
inoculation. The expectation of cure at this dose, without preparatory sensitiza-
tion, is about 0.1 per cent, but significant cure-rates can be obtained when host
resistance to the tumour has been stimulated by some experimental manipulation
(Cohen and Cohen, 1954b). Two or more cures in any single experimental group
may then be taken as indicative of a significant induced radiosensitization.
Irradiation technique
As in all previous experiments of this series, rontgen rays generated at 240
kVp, no added filters, HVL 0-34 mm. Cu, were used. For irradiation ofthe tumour
in situ, the mice were anaesthetized with intraperitoneal pentobarbital, and using
a 2 cm. diameter applicator at 25 cm. FSD, the radiation was directed through
the tumour retracted on to a wax block at a dose rate of 500 r/min. The attenu-
ation procedure was carried out by irradiation of minced tissue fragments in a
plastic welled slide with the same technical factors, but using a 5 cm. diameter
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field giving 600 r/min. with full back-scatter, as described in a previous communi-
cation (Cohen and Cohen, 1953a).
RESULTS
The results of all the experiments involving isogenic tissue inocula, and their
radiosensitizing properties, are shown in Table I. The first two items are from the
previously published report, and have been incorporated in the table for com-
parison with the new data.
TABLE I.-Radiosensitization of the C3H Mammary Tumour Induced by Radiation-
attenuated Isogenic Tissue
Dose in situ, 4200 r
In vitro Number cured at 3-month
dose Number of , cures
Type of inoculum (r) mice 3 months 6 months (%)
*Viable tumour isografts . . 3,500 . 54 . 7 0 . 13
*Arrested tumour isografts . . 5,000 . 38 . 19 10 . 50
Single tumour implant . . . 7,000 . 11 . 6 4
Multiple tumour "boosters" . 7,000 . 10 . 4 3
Tumour isograft with adjuvant . 7,000 . 9 . 5 3 l
tIrradiated tumour cytolysate . 7,000 . 10 . 0 0 r
Irradiated skin isograft. . . 7,000 . 22 . 11 6
Irradiated spleen isograft . . 7,000 . 10 . 2 2
Single tumour implant . . . 10,000 . 10 . 1 0
Multiple tumour "boosters". . 10,000 . 22 . 6 2 18
Irradiated skin isograft . . 10,000 . 12 . 1 0
Total irradiated isografts . - . 208 . 62 27 . 30
Non-irradiated tumour cytolysate . 0 . 11 . 0 0
Non-irradiated skin isograft . . 0 . 11 . 0 0 0
Uninoculated controls . . . 0 . 11 . 0 0 J
§Total controls . . . - . 33 . 0 0 . 0
* From previous data (Cohen and Cohen, 1956).
t This material was cytolyzed, that is dead, before irradiation.
§ To this group may be added 97 unattenuated "controls "from previous data, with no "cures"
after 4200 r in situ.
Comparison shows that the radiosensitizingeffect of attenuated isogenic tissue
is critically related to the attenuating dose. Whereas only 13 per cent three-month
cures were obtained with an attenuation dose of 3500 r, the cure rate approaches a
maximum with doses of 5000 and 7000 r, and then falls off sharply at 10,000 r.
Ofthe three groups, totalling 44 mice, that receivedinocula attenuated at 10,000 r,
only 8 (18 per cent) were cured at three months, while in the corresponding three
groups, totalling 43 mice, in the 7000 r attenuation category, 21 (50 per cent)
were cured at three months. This difference is significant (p < 0.01) indicating
a loss of radiosensitizing ability with increasing radiation dosage. An analogous
loss in immunizing ability of excessively irradiated homografts of Sarcoma-180
has been previously described by Goldfeder (1942).
There is reason to believe that with progressive over-dosage, there is not merely
a loss of antigenic power in the cells of the inoculum, but the presence of these
heavily irradiated cells may actually stimulate the growth of undamaged tumourA. COHEN AND L. COHEN
tissue in the host (Revesz, 1956; Scott, 1957) in a manner highly suggestive of
the tumour-enhancing properties of lyophilized tissues (Casey, 1934, 1941;
Kaliss, 1955). The attenuating efficiency relative to dosage is therefore a biphasic
curve whose optimum in the region of 6000 r is probably uniquely characteristic
of this host-tumour relationship, and, coincidentally or otherwise, happens to be
about the same as the median curative dose for the established tumour irradiated
in situ (Cohen and Cohen, 1953a).
Approximately halfofthetumours apparently curedat threemonthseventually
recurred. The injection of" booster" inocula, repeated at intervals over the whole
period ofobservation, did not significantly influence either the initial three-month
cure rate, nor did it prevent the late recurrences assessed at 6 months.
Freund's adjuvant was used (at the suggestion of J. B. Graham, personal
communication, 1957) in an attempt to intensify the sensitizing effect of the
attenuated tumour inocula. Under the conditions of this experiment, however,
the procedure did not raise the cure rate materially.
It can also be seen that new-born mouse skin isografts irradiated prior to
implantation are just as effective as the tumour isografts at the corresponding
doses. This result is, presumably, attributable to the common antigens possessed
by the two epithelial tissues (Bashford and Murray, 1906; Maculla, 1948).
A non-epithelial irradiated inoculum such as adult spleen seemed to be somewhat
less effective in this regard.
One very obvious trend was the complete loss of radiosensitizing ability when
killed (cytolyzed) tumour tissue was inoculated, either unirradiated (0/11 cures)
or previously irradiated with 7000 r (0/10 cures).
Non-irradiated skin isografts were ineffective (0/11 cures). There were also no
cures in the group of 11 uninoculated controls treated towards the end of this
series of experiments, indicating that no inherent increase in radiosensitivity
had appeared fortuitously during the serial transmission of this tumour line.
The over-all three-month cure rate of 30 per cent among the 208 mice receiving
irradiated inocula, compared with no cures among the concomitantly treated
controls, furnishes highly significant additional evidence of the radiosensitizing
properties ascribed to radiation-attenuated isografts.
In the group of 10 spontaneous mammary tumours in female mice that were
inoculated prior to treatment with autografts removed by biopsy and irradiated
at 7000 r, there were three cures (not shown in the table). This cure rate is not
significantly less than that obtained with isografts, suggesting that, in the C3H
mouse at least, conclusions derived from the relatively artificial experimental
conditions with grafted tumours, are still valid for the truly autogenous host-
tumour relationship.
DISCUSSION
All the foregoing results consistently support and reinforce the previously
proposed immunological hypothesis (Cohen and Cohen, 1956), that the radiation-
attenuated isograft had been rendered antigenic to the host, evoking a generalized
systemic immune reaction associated with increased radiosensitivity of the
established tumour treated in situ. If the hypothesis is correct, then ionizing
radiation plays a doubly useful role in this type of investigation: it is able to
render autogenous and isogenic tumours and tissues, normally incapable of
eliciting any immune response, perceptibly antigenic to their hosts; and, by
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measuringinducedchanges inradiosensitivity, itpermitsthedetectionofsubliminal
resistant states or immunizing factors not ordinarily exhibited in the autogenous
or isologous relationship. This method has enabled us to induce and detect what
amounts to a "systemic radiosensitizing factor" operating in an isologous
host-tumour relationship, analogous to the cellular "mobile resistance factor"
described by Prehn, Weaver and Algire (1954) in the case of non-isogenic homo-
logous tumour grafts.
The following facts, however, suggest that the phenomenon of induced radio-
sensitization cannot entirely be explained in conventional immunological terms:
Effective "antigen" is apparently confined to physically intact cells attenuated
at critical dose levels; repeated "booster" inocula fail to modify the result,
and addition of adjuvants (Freund's) does not enhance the effect; some other
irradiated tissues are just as effective as the attenuated tumour; and isologous
attenuated tumour antigen seems to be effective only when given to a mouse
already bearing a tumour.
Since neither isologous nor autogenous transplants can be considered antigenic
in the classical sense, it seems that the attenuated inoculum must contain some
new material, or antigen modified bythe irradiation procedure, capable ofinfluenc-
ing a pre-existing balance between the growing tumour and the resistance factors
of the host.
One is led to describe this type of interaction in terms ofbiological "informa-
tion theory" (Quastler, 1953), which is peculiarly suited to the dynamics of the
situation. Self-regulation of protein synthesis and tissue growth (Weiss, 1952)
apparently entails a "negative feedback" cycle regulated through the specific
tissue "markers" described by Burnet (1954, 1957). Such a cycle is readily
"modulated" by extraneous influences. In this case, inoculation with irradiated
tissue amounts to injection ofdisturbing " information "into the system. Ionizing
radiation, with its capacity for random disorientation of protein and nucleic
acid structure, could well distort the mechanism of normal information-transfer
between isogenic tissue and its host, equivalent, in cybernetic terminology, to the
superposition of "noise" or "equivocation" (Yockey, 1956) upon the specific
" signal ".
When tissues are irradiated in situ, the degree of equivocation, that is the
noise: signal ratio, becomes sufficient for the cells to lose their specific identity
and hence to be regarded as virtually foreign elements subject to the homograft
reaction (Medawar, 1946).
All factors inhibiting reticulo-endothelial function in the host, suppressing
the homograft reaction, will retard or prevent radiation responses. Total body
radiation which delays the onset of homograft immunity (Dempster, Lennox
and Boag, 1950) also reduces the radio-curability of tumours (Cohen and Cohen,
1953b), and the corticoid hormones (unpublished data) have been shown to possess
a similar action. Conversely, activation of host resistance by exhibition of" equi-
vocated" (irradiated) iso-antigens will facilitate radiation reactions and tumour
regression.
It should be noted too that the method of cytolysis, whereby the sensitizing
ability of the irradiated isograft is destroyed by repeated freeze-thawing, also
inactivates the nuclear antigen responsible for eliciting transplantation immunity
with homografts (Billingham, Brent and Medawar, 1956). As an interesting
corollary, the latent period of about two weeks before the effects of local irradi-
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ation become visible, is the same as that for transplantation immunity and many
other sensitization reactions.
In previous experiments (Cohen and Cohen, 1954a, 1955) with the C3H mam-
mary tumour grown in genetically alien F1 hybrid hosts, and with a mutant
tumour line in the homozygous mouse, it was shown that the dose of radiation
required to cure a tumour treated in situ was determined by immunogenetic
differences or antigenic diversification between the tumour and its host. This
rule now appears, in view of the foregoing discussion and particularly of the
current data on induced radiosensitization, to be a special case of a more general
law applicable to all irradiated metazoal tissues and tumours: Radiosensitivity
is afunction of antigenic equivocation between the irradiated tissue and its host.
SUMMARY
C3H mice bearing isografts of the C3H mammary adenocarcinoma were given
one or more inocula of isogenic tumour, skin or spleen, using structurally intact
as well as cytolyzed preparations, some unirradiated and others irradiated with
varying doses ofrontgen rays immediately prior to implantation. The originally
established tumours were then irradiated in situ with 4200 r, a dose at which the
expectation of cure is normally about 0.1 per cent. The cure rate at this dose
level in mice inoculated with living minced isogenic tumour tissue or neonatal
skin attenuated in the 5000 to 7000 r range, approaches 50 per cent, indicating a
very significant radiosensitizing effect. This attenuating dose is similar to the
median curative dose for the tumour treated in situ in unmodified hosts, and is
critical in that the radiosensitizing efficacy falls off sharply with attenuation doses
above or below the optimal range.
Repeated "booster" inocula, or the addition of Freund's adjuvant to the
attenuated tumour isografts showed no additional effect. Non-irradiated isogenic
skin, and dead (cytolyzed) tumour, whether irradiated or not, were completely
ineffective.
A group of female mice bearing autogenous mammary tumours and pre-
treated with attenuated autografts also showed a substantial cure rate at the test
dose.
It seems that irradiation of isogenic or autogenous inocula produces antigens
capable ofsensitizingestablishedtumours to subsequent irradiation. Consideration
of the whole series of experiments leads to the conclusion that radiation acts
through equivocation of specific identity markers, evoking a virtual homograft
reaction against the irradiated isologous or autogenous tissues.
All the necessary facilities for the maintenance of the animals used in these
experiments were supplied at the South African Institute for Medical Research,
through thegenerous co-operation of Professor J. F. Murray. The work was sup-
ported in part through the Farquhar Bequest Cancer Research Fund. We wish
to thank Mrs. Shelley Jacobson for her invaluable technical assistance.
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